 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval% F" K* \, J! N2 v+ o- z
' x7 M( ~- A2 P2 K3 Z
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.5 V$ T8 P% T/ s2 A6 V; W9 w
* ?5 M9 ~7 C- {& } Q. `; }- Q9 PBY THE EDMONTON JOURNAL FEBRUARY 16, 2007% y: E& {" t1 O; [) w" j7 o0 S0 j
! K7 }: r4 E2 N: g
5 z$ T3 J3 e$ @: c9 j
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.6 y, x5 {, m5 ^8 n* O
3 ^6 f) Q! p0 j1 k! v
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."9 w1 o1 `: } l; {" l1 e: m$ r
( h" x6 S" q9 q6 T
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.- ^/ a. O8 J7 Y$ W. N
9 n2 B8 A O: W
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
! d3 e* I, N$ H# |2 j" m) r' w/ s! R9 y) L0 v5 n
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
2 w2 K$ w) f4 F. A1 P; T
% s# e, _% z' [7 p"As a scientist, it's one of the highlights of my CAREER," Shan said.- y: N g3 E: i0 Y9 J! l. F4 j
8 `" m- p9 d7 Y/ A. ?
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
/ K+ m: i/ O& g+ ~, Q( V ]" G" w: `7 `, P+ |- S: i
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.* _+ ~0 [1 Y8 f/ i" X! R
! G8 { X1 J Z0 s; d
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
5 P$ {1 h$ Y# e- c( k: R
! u- k: B2 r3 E- B: {* IThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman. V4 o! ~* |; L* R" Y5 U( P
8 u* X3 }' _/ v; ^% U; C, k. ?: Q7 o3 l0 Z1 I) X- Z
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
" V/ R, e I5 M8 l
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
# `# V o, O3 d
发表于 2015-2-28 19:45
